NextGen Invitro Diagnostics Pvt Ltd

HealthTech

NextGen In-Vitro Diagnostics (NGIVD) is at the forefront of the healthcare industry, focusing on revolutionizing diagnostics through its innovative Multiplexing technology. This technology is designed to enhance the efficiency and accuracy of diagnostic tests, particularly in the area of infectious diseases. NGIVD's commitment lies in offering healthcare solutions that are not only reliable and clinically actionable but also accessible to diverse populations, including those in resource-limited settings. NGIVD's diagnostic solutions are particularly geared towards diseases like Tuberculosis, Leishmaniasis, and various fevers, providing healthcare technicians with tools that enable the identification of multiple disease markers from a single sample. This approach significantly lowers the costs and increases the impact of diagnostic procedures, making them more scalable and measurable. Their products are tailored to serve a broad range of customers, including those in life science research, biotech, biopharma, diagnostics, and pharmaceuticals.